Grapefruit USA Inc (GPFT)

[mr_sano]

Again if one doesn’t know the terms, fee structure and territory of a licensing agreement, then it’s impossible to calculate margins and therefore ROi. This is the modus operandi....insinuate they have exclusivity but in reality it’s all shrouded in secrecy...feel free to address the issue of why the pharma and Licensor would rely on a penny stock financed by convertible notes to be the driving distributor of a supposedly disruptive product. I can’t wait for the analysis.,.this should be good!